Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Study of SGN1 in Patients With Advanced Solid Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05038150
Recruitment Status : Not yet recruiting
First Posted : September 8, 2021
Last Update Posted : September 8, 2021
Sponsor:
Information provided by (Responsible Party):
Guangzhou Sinogen Pharmaceutical Co., Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 30, 2023
Estimated Study Completion Date : January 31, 2024